Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/02/2010WO2010098286A1 Pharmaceutical preparation containing mineralcorticoid receptor antagonist
09/02/2010WO2010098261A1 Risperidone-containing transdermal preparation and adhesive patch using same
09/02/2010WO2010098251A1 Loxoprofen derivative and pharmaceutical containing same
09/02/2010WO2010098230A1 Transdermal preparation
09/02/2010WO2010098166A1 Cell adhesion inhibitor and use thereof
09/02/2010WO2010098145A1 Oxyindole derivatives with motilin receptor agonistic activity
09/02/2010WO2010098125A1 Retinoid x receptor partial agonist compound
09/02/2010WO2010098103A1 Equol-producing bacterium and use thereof
09/02/2010WO2010098080A1 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same
09/02/2010WO2010097816A1 Flavanoid compounds and process for preparation thereof
09/02/2010WO2010097788A2 Visfatin therapeutic agents for the treatment of acne and other conditions
09/02/2010WO2010097703A1 Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
09/02/2010WO2010097700A1 Bendamustine cyclopolysaccharide compositions
09/02/2010WO2010097641A1 SIGMA(σ) RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR MECHANISMS, EXHIBITING PROTOTYPICAL CYTOPROTECTIVE AND ALSO ANTICANCER ACTIVITY
09/02/2010WO2010097626A2 Compounds and methods relating thereto
09/02/2010WO2010097595A1 Compositions for use in cardioplegia comprising esmolol and adenosine
09/02/2010WO2010097586A1 Enzyme inhibitors
09/02/2010WO2010097583A1 Esomeprazole potassium polymorph and its preparation
09/02/2010WO2010097576A1 1, 4-disubstituted piperidines as vasopressin receptor via antagonists
09/02/2010WO2010097501A2 A combination treatment
09/02/2010WO2010097471A2 Protein targets in disease
09/02/2010WO2010097469A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097468A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097467A1 N-phenylacetamide derivatives, which inhibit the enzyme soat-1 and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097465A1 Dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097464A1 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097414A1 Improved design of small-interfering rna
09/02/2010WO2010097410A1 Novel bronchodilating diazaheteroaryls
09/02/2010WO2010097395A1 Pyrazole derivatives used as ccr4 receptor antagonists
09/02/2010WO2010097381A1 Uses of nk receptor antagonists
09/02/2010WO2010097379A1 Substituted pyrimidin derivatives and their medical use
09/02/2010WO2010097374A1 Compounds for use as bradykinin b1 antagonists
09/02/2010WO2010097373A1 Compounds for use as bradykinin b1 antagonists
09/02/2010WO2010097372A1 Compounds as bradykinin b1 antagonists
09/02/2010WO2010097371A1 Ceramide-analogous metabolites
09/02/2010WO2010097368A1 Isoxazole / o-pyridine derivatives with ethyl and ethenyl linker
09/02/2010WO2010097335A1 Imidazo [1, 2 -a] pyridines as jnk modulators
09/02/2010WO2010097334A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097332A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097255A2 Beverage containing a polymeric polyphenol
09/02/2010WO2010097248A1 Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
09/02/2010WO2010097229A2 Amorphous salt of a macrocyclic inhibitor of hcv
09/02/2010WO2010097201A1 Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa
09/02/2010WO2010097188A1 Inhalation particles comprising a salt of carmoterol and a corticosteroid
09/02/2010WO2010097172A1 New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
09/02/2010WO2010097115A1 Pharmaceutical formulations comprising 4-{(1r)-2- [(6-{2-[(2,6-dichlorobenzyl)oxy] ethoxy}hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol
09/02/2010WO2010097114A1 Novel combination of therapeutic agents
09/02/2010WO2010097092A1 Treatment of dyskinesia related disorders
09/02/2010WO2010097091A1 Methods of administering (4ar, 1oar)-i-n-propyl-i, 2,3,4a7 s1io7 ioa-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof
09/02/2010WO2010097087A1 Catecholamine derivatives and prodrugs thereof
09/02/2010WO2010096987A1 Use of patchouli alcohol in medicament preparation
09/02/2010WO2010096925A1 Homotaurine-supplemented and/or enriched edible material, methods of preparation an d uses
09/02/2010WO2010096906A1 Ethyl gallate and related compounds as a treatment for sepsis and septic shock
09/02/2010WO2010096886A2 Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
09/02/2010WO2010096869A1 An agent for improving inotropy and lusitropy, and for treating diseases causing or caused by poor contractility or relaxation of the heart
09/02/2010WO2010096868A1 Topical foam composition
09/02/2010WO2010096854A1 Methods of modulating the activity of the mc3 and/or mc4 receptors and treatment of conditions related to these receptors
09/02/2010WO2010096853A1 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
09/02/2010WO2010080452A3 siRNA COMPOUNDS AND METHODS OF USE THEREOF
09/02/2010WO2010080339A4 Phenylephrine formulations with improved stability
09/02/2010WO2010079504A3 Stable r (+) -lansoprazole amine salt and a process for preparing the same
09/02/2010WO2010075372A9 Inhibitors of mre11, rad50 and/or nbs1
09/02/2010WO2010068037A9 Anti-cancer composition containing 4-hexylresorcinol-1,3-diol as active ingredient
09/02/2010WO2010064172A3 Isolated compounds from phaleria macrocarpa as anti-cancer agents
09/02/2010WO2010057028A9 Treatment of proteinopathies using a farnesyl transferase inhibitor
09/02/2010WO2010053861A3 Biologically active amides
09/02/2010WO2010053606A9 Small-molecule inhibitors of protein synthesis inactivating toxins
09/02/2010WO2010048384A3 Arformoterol and tiotropium compositions and methods for use
09/02/2010WO2010048149A3 Heterocyclic modulators of gpr119 for treatment of disease
09/02/2010WO2010044885A3 Soluble mtor complexes and modulators thereof
09/02/2010WO2010036497A3 Selective estrogen repector modulator for the treatment of osteoarthritis
09/02/2010WO2010034779A3 Composition and method for treatment of preterm labor
09/02/2010WO2010030757A3 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
09/02/2010WO2010028108A3 Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor
09/02/2010WO2010019417A3 Chymase inhibitors
09/02/2010WO2009158118A3 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria
09/02/2010WO2009115893A3 Novel 2 ', 2 ', 3 ', 3 ' -tetrasubstiuted nucleoside derivatives
09/02/2010WO2009114097A4 Method of modulating t cell-dependent immune responses
09/02/2010WO2009112274A3 Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
09/02/2010WO2009112273A3 Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
09/02/2010WO2009108118A9 16 alpha, 17 alpha-acetal glucocorticosteroidal derivatives and their use
09/02/2010WO2009094426A8 13,13-dimethyl-des-c,d analogs of 1alpha, 25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof
09/02/2010WO2009094181A8 Ph-responsive nanostructures
09/02/2010WO2009092602A8 Anti-angiogenic compounds
09/02/2010WO2009027614A3 Method for splitting omeprazole salts
09/02/2010WO2007022041A3 Mutations and polymorphisms of hdac3
09/02/2010US20100223680 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
09/02/2010US20100223678 protein isoforms of the pif-family and uses thereof
09/02/2010US20100222875 Method for forming a porous stent coating
09/02/2010US20100222873 Self-Buffering Medical Implants
09/02/2010US20100222867 Drug delivery from stents
09/02/2010US20100222591 New Compounds
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222439 Beverage containing a polymeric polyphenol
09/02/2010US20100222438 Methods compositions and article of manufacture for modulating bone growth
09/02/2010US20100222437 Composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases
09/02/2010US20100222436 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
09/02/2010US20100222435 Modified-release formulations of a bupropion salt
09/02/2010US20100222434 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
09/02/2010US20100222432 Synthetic Carbon Nanotubes
1 ... 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 ... 7860